Microbiological findings, antibiotic resistance rates and prescription practices for older women with recurrent urinary tract infections: a descriptive study alongside a multinational randomized controlled trial (ImpresU)
JAC-Antimicrobial Resistance · 02.07.2026 · 8 (4)
DOI: 10.1093/jacamr/dlag121 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 04.07.2026. Verfasst von Silje Rebekka Heltveit-Olsen und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, …. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Programming Initiative on Antimicrobial Resistance, Research Council of Norway, Swedish Research Council.
Abstract (Originalsprache)
Objectives
To describe microbiological findings during asymptomatic and symptomatic phases in older women with recurrent urinary tract infections (rUTIs), to evaluate whether antimicrobial resistance patterns of Escherichia coli among methenamine hippurate users differ from untreated controls, and to explore prescription patterns of UTI antibiotics.
Methods
This was a descriptive study alongside a multinational randomized controlled trial (ImpresU). Women aged ≥70 years with rUTIs were recruited from general practice in Norway, Sweden, Poland and the Netherlands between December 2019 and June 2022. Participants were randomized to methenamine hippurate 1 g or placebo twice daily for 6 months, followed by a 6 month follow-up period. Urinary samples were collected at baseline (asymptomatic) and during acute UTIs.
Results
We included 281 women. A dominating uropathogen ≥105 cfu/mL was detected in 29% of the baseline urine samples. Of the 178 urinary cultures taken at acute UTIs, 163 (92%) had bacterial growth, of which a minority (10%) were reported as mixed flora. E. coli was most frequently detected both at baseline and in acute UTIs (present in any concentration in 32% versus 60% of urine samples), with highest resistance to amoxicillin (36% versus 43%), trimethoprim (16% versus 22%) and amoxicillin/clavulanate (12% versus 16%). ESBL-producing E. coli at baseline were rare (4.1%). Phylogenetic subgroup B2 was the most frequent E. coli phylotype at baseline (52%). No relevant differences in antimicrobial resistance rates were found between methenamine hippurate users and controls. Narrow-spectrum antibiotics were widely prescribed, and guideline adherence was high.
Conclusions
Physicians should be aware that 29% of older women with rUTIs in the community may have significant bacterial findings in their urine during asymptomatic phases.
Autor:innen und Institutionen
- The Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, Oslo 0318, Norway.
- Department of Medical Microbiology, Vestfold Hospital Trust, Tønsberg, Norway.
- General Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Box 453, Gothenburg SE-405 30, Sweden.
- FoUUI-Centrum Södra Älvsborg, Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden, Sven Eriksonsplatsen 4, Borås SE-503 38, Sweden.
- Närhälsan Heimdal Primary Health Care Centre, Stengärdsgatan 22, Borås 50334, Sverige.
- Allmänmedicinskt Centrum, Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden, Guldhedsgatan 5A, Gothenburg SE-413 20, Sweden.
ORCID-Profile: Silje Rebekka Heltveit-Olsen, Pär-Daniel Sundvall, Ronny Gunnarsson, Anna Kowalczyk, Maciej Godycki-Cwirko, Tamara N Platteel, Sara Sofia Lithén, Sigurd Høye
Förderung
- Joint Programming Initiative on Antimicrobial Resistance
- Research Council of Norway
- Swedish Research Council
- Region Västra Götaland
- ZonMw, the Netherlands
- National Science Centre, Poland
- Norwegian Surveillance System for Antimicrobial Drug Resistance
- Gidske and Peter Jacob Sørensens Research Trust
Zitieren
APA
Heltveit-Olsen, S. R., Grude, N., Snaebjörnsson Arnljots, E., Sundvall, P. D., Gunnarsson, R., Kowalczyk, A., Godycki-Cwirko, M., Platteel, T. N., Groen, W. G., Lithén, S. S., Sundvall, S., Karami, N., Verheij, T. J. M., Hertogh, C. M. P. M., Lindbæk, M., Åhrén, C., & Høye, S. (2026). Microbiological findings, antibiotic resistance rates and prescription practices for older women with recurrent urinary tract infections: a descriptive study alongside a multinational randomized controlled trial (ImpresU). JAC-Antimicrobial Resistance, 8(4). https://doi.org/10.1093/jacamr/dlag121
Vancouver
Heltveit-Olsen SR, Grude N, Snaebjörnsson Arnljots E, Sundvall PD, Gunnarsson R, Kowalczyk A, et al. Microbiological findings, antibiotic resistance rates and prescription practices for older women with recurrent urinary tract infections: a descriptive study alongside a multinational randomized controlled trial (ImpresU). JAC-Antimicrobial Resistance. 2026;8(4). doi:10.1093/jacamr/dlag121
BibTeX
@article{HeltveitOlsen2026,
author = {Heltveit-Olsen, Silje Rebekka and Grude, Nils and Snaebjörnsson Arnljots, Egill and Sundvall, Pär-Daniel and Gunnarsson, Ronny and Kowalczyk, Anna and Godycki-Cwirko, Maciej and Platteel, Tamara N and Groen, Wim G and Lithén, Sara Sofia and Sundvall, Sofia and Karami, Nahid and Verheij, Theo J M and Hertogh, Cees M P M and Lindbæk, Morten and Åhrén, Christina and Høye, Sigurd},
title = {Microbiological findings, antibiotic resistance rates and prescription practices for older women with recurrent urinary tract infections: a descriptive study alongside a multinational randomized controlled trial (ImpresU)},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {4},
doi = {10.1093/jacamr/dlag121}
}
EUVIMED